Vertex Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development of transformative therapies for serious diseases, particularly cystic fibrosis (CF). Renowned for its innovative, proprietary approaches, Vertex has revolutionized CF treatment with its suite of approved therapies, significantly improving patient outcomes. The company is actively broadening its research and development efforts into new therapeutic areas, reinforcing its status as an industry front-runner. With a strong commitment to innovation and a solid financial foundation, Vertex is well-positioned for continued growth and value creation in the rapidly evolving healthcare market.

NASDAQ

USA

HEALTHCARE

BIOTECHNOLOGY

50 NORTHERN AVENUE, BOSTON, MA, UNITED STATES, 02210

December

$112 Billion

$4.71 Billion

30.67

14.2

$0.00

0.0%

0.322